BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 23894100)

  • 21. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
    Pinhal-Enfield G; Ramanathan M; Hasko G; Vogel SN; Salzman AL; Boons GJ; Leibovich SJ
    Am J Pathol; 2003 Aug; 163(2):711-21. PubMed ID: 12875990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
    Liu X; Wang C; Ye Z; Kijlstra A; Yang P
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system.
    Lendemans S; Kreuzfelder E; Rani M; Bayeeh E; Schade FU; Flohé SB; Waydhas C; Flohé S
    J Trauma; 2007 Oct; 63(4):740-6. PubMed ID: 18089999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of MAPK in Kupffer cell toll-like receptor (TLR) 2-, TLR4-, and TLR9-mediated signaling following trauma-hemorrhage.
    Thobe BM; Frink M; Hildebrand F; Schwacha MG; Hubbard WJ; Choudhry MA; Chaudry IH
    J Cell Physiol; 2007 Mar; 210(3):667-75. PubMed ID: 17117477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
    Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
    Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop.
    Wenink MH; Santegoets KC; Broen JC; van Bon L; Abdollahi-Roodsaz S; Popa C; Huijbens R; Remijn T; Lubberts E; van Riel PL; van den Berg WB; Radstake TR
    J Immunol; 2009 Dec; 183(11):6960-70. PubMed ID: 19915052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression of TLR pathway molecules in peripheral blood mononuclear cells and their relationship with tumor invasion and cytokine secretion in laryngeal carcinoma.
    Starska K; Forma E; Bryś M; Głowacka E; Lewy-Trenda I; Lukomski M; Krajewska WM
    Adv Med Sci; 2012 Jun; 57(1):124-35. PubMed ID: 22240197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dasatinib inhibits the secretion of TNF-alpha following TLR stimulation in vitro and in vivo.
    Fraser CK; Lousberg EL; Kumar R; Hughes TP; Diener KR; Hayball JD
    Exp Hematol; 2009 Dec; 37(12):1435-44. PubMed ID: 19786067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional consequences of CD36 downregulation by TLR signals.
    Zamora C; Cantó E; Nieto JC; Angels Ortiz M; Juarez C; Vidal S
    Cytokine; 2012 Oct; 60(1):257-65. PubMed ID: 22795952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis.
    Kowalski ML; Wolska A; Grzegorczyk J; Hilt J; Jarzebska M; Drobniewski M; Synder M; Kurowski M
    Mediators Inflamm; 2008; 2008():132732. PubMed ID: 18584044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute allograft rejection in human liver transplant recipients is associated with signaling through toll-like receptor 4.
    Testro AG; Visvanathan K; Skinner N; Markovska V; Crowley P; Angus PW; Gow PJ
    J Gastroenterol Hepatol; 2011 Jan; 26(1):155-63. PubMed ID: 21175809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
    Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
    Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents.
    Shin BH; Ge S; Mirocha J; Karasyov A; Vo A; Jordan SC; Toyoda M
    Transplantation; 2014 Feb; 97(3):294-300. PubMed ID: 24342979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.
    Zhao J; Zhao S; Zhou G; Liang L; Guo X; Mao P; Zhou X; Wang H; Nan Y; Xu D; Yu J
    Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis.
    Popa C; van Lieshout AW; Roelofs MF; Geurts-Moespot A; van Riel PL; Calandra T; Sweep FC; Radstake TR
    Cytokine; 2006 Oct; 36(1-2):51-6. PubMed ID: 17166737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maturation of Toll-like receptor 1-4 responsiveness during early life.
    Liao SL; Yeh KW; Lai SH; Lee WI; Huang JL
    Early Hum Dev; 2013 Jul; 89(7):473-8. PubMed ID: 23591080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental model of equine alveolar macrophage stimulation with TLR ligands.
    Waldschmidt I; Pirottin D; Art T; Audigié F; Bureau F; Tosi I; El Abbas S; Farnir F; Richard E; Dupuis MC
    Vet Immunol Immunopathol; 2013 Sep; 155(1-2):30-7. PubMed ID: 23815824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis.
    Holle JU; Windmöller M; Lange C; Gross WL; Herlyn K; Csernok E
    Rheumatology (Oxford); 2013 Jul; 52(7):1183-9. PubMed ID: 23407387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can the Toll-like receptors 4 expression in peripheral blood mononuclear cells help assess the effectiveness of immunosuppression and the chance of a future good renal transplant function?
    Zmonarski SC; Madziarska K; Golebiowski T; Banasik M; Mazanowska O; Madziarski M; Krajewska M
    Transpl Immunol; 2019 Apr; 53():43-50. PubMed ID: 30592973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.